40
Participants
Start Date
January 1, 2018
Primary Completion Date
December 31, 2020
Study Completion Date
March 16, 2021
CDIAG regimen
Chidamide 30mg orally twice every week for 2 weeks on days 1, 4, 8, 11, decitabine 20mg/m2 intravenously daily for 5 days (d1-d5) and IAG regimen (cytarabine, 10 mg/m2 subcutaneously every 12 h on days 4-17; idarubicin, 5mg intravenously every other day on days 4, 6, 8, 10, 12, 14; and concurrent granulocyte colony-stimulating factor, 200mg/m2/day subcutaneously daily on days 3-17.
The First Affliated Hospital of Soochow University, Suzhou
Jining Medical University
OTHER
The First Affiliated Hospital of Soochow University
OTHER